Showing 11,501 - 11,520 results of 24,164 for search '(( 59 ((0 decrease) OR (a decrease)) ) OR ( 50 ((we decrease) OR (mean decrease)) ))', query time: 0.78s Refine Results
  1. 11501

    Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis by Sara Llufriu (323179)

    Published 2014
    “…At 6 months, patients treated with MSCs had a trend to lower mean cumulative number of GEL (3.1, 95% CI = 1.1–8.8 vs 12.3, 95% CI = 4.4–34.5, p = 0.064), and at the end of study to reduced mean GEL (−2.8±5.9 vs 3±5.4, p = 0.075). …”
  2. 11502

    Exploration of muscle loss and metabolic state during prolonged critical illness: Implications for intervention? by Liesl Wandrag (20467)

    Published 2019
    “…The data are consistent with a conclusion that a time based assumption of a tipping point does not exist.…”
  3. 11503

    Table_1_Effectiveness, Healthcare Resource Utilization and Adherence to Subcutaneous Interferon Beta-1a According to Age in Patients With Multiple Sclerosis: A Cohort Study Using a... by Arthur Allignol (4017428)

    Published 2021
    “…</p><p>Results: Of the 5,340 patients included in the analysis, there was a high proportion of patients free from relapse across all age groups (range: 94.1–95.4%), with a numerical decrease in the number of MRI performed by age (mean: 0.25, 18–30 years; 0.20, 31–40 years; 0.16, 41–50 years; 0.14, ≥51 years). …”
  4. 11504
  5. 11505

    Use of GPCR-HIT to show effect of AT<sub>1</sub> receptor activation on CCR2/Gα<sub>i1</sub> proximity. by Mohammed Akli Ayoub (176430)

    Published 2015
    “…Data are presented as mean ± SEM of three (C) or five (D) independent experiments. …”
  6. 11506

    Table_1_Effectiveness, Healthcare Resource Utilization and Adherence to Subcutaneous Interferon Beta-1a According to Age in Patients With Multiple Sclerosis: A Cohort Study Using a... by Arthur Allignol (4017428)

    Published 2021
    “…</p><p>Results: Of the 5,340 patients included in the analysis, there was a high proportion of patients free from relapse across all age groups (range: 94.1–95.4%), with a numerical decrease in the number of MRI performed by age (mean: 0.25, 18–30 years; 0.20, 31–40 years; 0.16, 41–50 years; 0.14, ≥51 years). …”
  7. 11507
  8. 11508

    DataSheet_1_Patient-Reported Outcomes-Guided Adaptive Radiation Therapy for Head and Neck Cancer.docx by Sarah Weppler (10931013)

    Published 2021
    “…Dose-PRO relationships were strongest between delivered pharyngeal constrictor Dmean and patient-reported dysphagia, with MDADI composite scores (mean ± SD) of 25.7 ± 18.9 for patients with Dmean <50 Gy vs. 32.4 ± 17.1 with Dmean ≥50 Gy. …”
  9. 11509
  10. 11510

    Table 2_Global burden and trends of norovirus-associated diseases from 1990 to 2021 an observational trend study.xlsx by MengLan Zhu (20517257)

    Published 2025
    “…However, norovirus remains highly contagious, especially among children and the older adult. Projections suggest a continued decrease in the burden of such diseases by 2035. …”
  11. 11511

    Table 5_Global burden and trends of norovirus-associated diseases from 1990 to 2021 an observational trend study.xlsx by MengLan Zhu (20517257)

    Published 2025
    “…However, norovirus remains highly contagious, especially among children and the older adult. Projections suggest a continued decrease in the burden of such diseases by 2035. …”
  12. 11512

    Table 3_Global burden and trends of norovirus-associated diseases from 1990 to 2021 an observational trend study.xlsx by MengLan Zhu (20517257)

    Published 2025
    “…However, norovirus remains highly contagious, especially among children and the older adult. Projections suggest a continued decrease in the burden of such diseases by 2035. …”
  13. 11513

    Image 1_Global burden and trends of norovirus-associated diseases from 1990 to 2021 an observational trend study.png by MengLan Zhu (20517257)

    Published 2025
    “…However, norovirus remains highly contagious, especially among children and the older adult. Projections suggest a continued decrease in the burden of such diseases by 2035. …”
  14. 11514

    Table 1_Global burden and trends of norovirus-associated diseases from 1990 to 2021 an observational trend study.xlsx by MengLan Zhu (20517257)

    Published 2025
    “…However, norovirus remains highly contagious, especially among children and the older adult. Projections suggest a continued decrease in the burden of such diseases by 2035. …”
  15. 11515

    Table 4_Global burden and trends of norovirus-associated diseases from 1990 to 2021 an observational trend study.xlsx by MengLan Zhu (20517257)

    Published 2025
    “…However, norovirus remains highly contagious, especially among children and the older adult. Projections suggest a continued decrease in the burden of such diseases by 2035. …”
  16. 11516

    Image_1_Can nirmatrelvir/ritonavir treatment shorten the duration of COVID-19 isolation?.pdf by Haein Kim (4839594)

    Published 2022
    “…Clinical characteristics were similar between groups. Viral loads decreased significantly faster in the nirmatrelvir/ritonavir group compared with the supportive care group (P < 0.001), and the slope was significantly steeper (–2.99 ± 1.54 vs. –1.44 ± 1.52; P < 0.001). …”
  17. 11517
  18. 11518
  19. 11519
  20. 11520